Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00349778 · BASELINE

Baseline characteristics

High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma · Source last updated 2017-12-12

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      102
    units
    Participants
groups
  1. description
    Cyclophosphamide + Etoposide + Melphalan + Carmustine with Filgrastim
    id
    BG000
    title
    High-Dose Sequential Therapy
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          91
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          11
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          34
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          68
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          10
        title
        Hispanic or Latino
      2. measurements
        1. group Id
          BG000
          value
          85
        title
        Not Hispanic or Latino
      3. measurements
        1. group Id
          BG000
          value
          7
        title
        Unknown or Not Reported
      title
      Ethnicity
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Ethnicity (NIH/OMB)
    unit Of Measure
    Participants
population Description
all patients who proceeded to transplant on trial
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      102
    units
    Participants
groups
  1. description
    Cyclophosphamide + Etoposide + Melphalan + Carmustine with Filgrastim
    id
    BG000
    title
    High-Dose Sequential Therapy
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          0
        title
        <=18 years
      2. measurements
        1. group Id
          BG000
          value
          91
        title
        Between 18 and 65 years
      3. measurements
        1. group Id
          BG000
          value
          11
        title
        >=65 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Categorical
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          34
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          68
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          10
        title
        Hispanic or Latino
      2. measurements
        1. group Id
          BG000
          value
          85
        title
        Not Hispanic or Latino
      3. measurements
        1. group Id
          BG000
          value
          7
        title
        Unknown or Not Reported
      title
      Ethnicity
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Ethnicity (NIH/OMB)
    unit Of Measure
    Participants
population Description
all patients who proceeded to transplant on trial

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice